Ben Tre Pharmaceutical JSC (HOSE:DBT)

Market Cap	250.43B +1.6%
Revenue (ttm)	860.31B -0.9%
Net Income	12.85B -2.6%
EPS	614.00 -13.1%
Shares Out	21.97M
PE Ratio	18.57
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,436
Average Volume	48,266
Open	11,500
Previous Close	11,400
Day's Range	11,300 - 11,500
52-Week Range	9,990 - 12,150
Beta	0.40
RSI	60.43
Earnings Date	May 7, 2026

About HOSE:DBT

Ben Tre Pharmaceutical Joint Stock Company manufactures, distributes, and sells pharmaceutical products in Vietnam and internationally. The company offers drugs in injectable, infusion, pill, and lotion forms. The company provides products covering various therapeutic areas, including central nervous system, respiratory system, endocrinology, obstetrics and gynecology, anti-allergic, cardiovascular, antibiotics, anti-fungal, anti-viral, musculoskeletal, vitamins and minerals, digestive, hepatobiliary and urinary, pain relief, fever reducer, ant...

• Industry: Pharmaceutical Preparations
• Founded: 1963
• Employees: 781
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: DBT

Financial Performance

In 2025, HOSE:DBT's revenue was 860.31 billion, a decrease of -0.93% compared to the previous year's 868.41 billion. Earnings were 12.85 billion, a decrease of -2.66%.